CONCORD DRUGS
Back to Cashflow Statement
|
CONCORD DRUGS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1.43 Cr | ₹0.28 Cr | ₹0.62 Cr | ₹1.68 Cr |
What is the latest Cash Flow from Financing Activities ratio of CONCORD DRUGS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-1.43 Cr |
| Mar2024 | ₹0.28 Cr |
| Mar2023 | ₹0.62 Cr |
| Mar2022 | ₹1.68 Cr |
How is Cash Flow from Financing Activities of CONCORD DRUGS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1.43 Cr | Negative | |
| Mar2024 | ₹0.28 Cr | -54.65 | |
| Mar2023 | ₹0.62 Cr | -62.84 | |
| Mar2022 | ₹1.68 Cr | - | |
Compare Cash Flow from Financing Activities of peers of CONCORD DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD DRUGS | ₹99.4 Cr | -5.5% | 5.2% | 12.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 0.9% | 0% | -11% | Stock Analytics | |
CONCORD DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD DRUGS | -5.5% |
5.2% |
12.3% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses